Charming Medical Limited Class A Ordinary Shares
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Charming Medical Limited (Nasdaq:MCTA) is a Hong Kong-based holding company that, through its subsidiaries under the Beauty Lab brand, provides Traditional Chinese Medicine (TCM)-inspired beauty, wellness, and postpartum services and products via four wellness centers in Hong Kong. Core offerings include womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, TCM-inspired prenatal massages, Indonesian traditional abdominal binding, and tuina massage; TCM-inspired supplements and beauty products such as home herbal uterine care patches, probiotic intimate washes, Yin nourishing pill sets, ginseng soothing anti-allergy moisturizing washes, and scalp health formulations; and technical training, dietary therapy consultancy, and franchise services for beauty salons and massage centers targeting women's health issues like premenstrual syndrome, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopause, breast health, endocrine balance, and men's wellness needs. Founded in 2016 with initial subsidiaries incorporated from 2016 through 2021, the company is headquartered at Units 1803-1806, 18/F, Hang Lung Centre, 2-20 Paterson Street, Causeway Bay, Hong Kong, and became the holding entity in November 2024 through intermediate holding company Beautylab Group Medical Limited. In October 2025, it completed an initial public offering of 1,600,000 Class A ordinary shares at $4.00 per share for gross proceeds of $6.4 million, followed by the full exercise of the over-allotment option for an additional 240,000 shares raising total proceeds to approximately $7.36 million, with net proceeds allocated to business and geographic expansion, strategic investments and acquisitions, research and development, and working capital.
Portnoy Law Firm Announces Class Action on Behalf of Charming Medical Limited Investors
Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
Bragar Eagel & Squire, P.C. Urges Charming Medical (MCTA) Investors With Large Losses to Contact the Firm Before the February 17th Class Action Lead Plaintiff Deadline
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA
Deadline Approaching: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Deadline Soon: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Deadline Alert: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Bragar Eagel & Squire, P.C. Urges Charming Medical (MCTA) Investors With Large Losses to Contact the Firm Before the February 17th Class Action Lead Plaintiff Deadline
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA
Bronstein, Gewirtz & Grossman LLC Urges Charming Medical Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
CHARMING MEDICAL CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Urges Charming Medical (MCTA) Investors With Large Losses to Contact the Firm Before February 17th
Bronstein, Gewirtz & Grossman LLC Urges Charming Medical Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
Bragar Eagel & Squire, P.C. Urges Charming Medical Limited Stockholders With Large Losses to Contact the Firm Before the February 17th Lead Plaintiff Deadline